{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:56:07Z","timestamp":1790704567419,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.ejca.2022.10.013","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T21:56:25Z","timestamp":1666821385000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle"],"prefix":"10.1016","volume":"178","author":[{"given":"Sami","family":"Antoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Lanoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Ammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siham","family":"Farhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9493-0238","authenticated-orcid":false,"given":"Caroline","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Planchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Routier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Laure","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Messayke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0741-2118","authenticated-orcid":false,"given":"Stephane","family":"Champiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marie","family":"Michot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0888-0842","authenticated-orcid":false,"given":"Salim","family":"Laghouati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lambotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Marabelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vickie","family":"Baracos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"33","key":"10.1016\/j.ejca.2022.10.013_bib1","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1200\/JCO.20.00995","article-title":"Five-year outcomes with nivolumab in patients with wild-type BRAF advanced melanoma","volume":"38","author":"Robert","year":"2020","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.013_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","article-title":"Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer","volume":"28","author":"Derosa","year":"2022","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ejca.2022.10.013_bib3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1158\/1078-0432.CCR-18-0793","article-title":"Long-term survival in patients responding to anti-PD-1\/PD-L1 therapy and disease outcome upon treatment discontinuation","volume":"25","author":"Gauci","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2022.10.013_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.755735","article-title":"Editorial: pathophysiological interrelationship between obesity, metabolic diseases, and cancer","volume":"11","author":"Gahete","year":"2021","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2022.10.013_bib5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer \u2013 viewpoint of the IARC working group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejca.2022.10.013_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.10.013_bib7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s40425-019-0699-5","article-title":"The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients","volume":"7","author":"Donnelly","year":"2019","journal-title":"J Immunother cancer"},{"issue":"4","key":"10.1016\/j.ejca.2022.10.013_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","article-title":"Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer","volume":"6","author":"Kichenadasse","year":"2020","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.10.013_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable","volume":"7","author":"Cortellini","year":"2019","journal-title":"J Immunother cancer"},{"key":"10.1016\/j.ejca.2022.10.013_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lungcan.2019.11.011","article-title":"The impact of body mass index on the efficacy of anti-PD-1\/PD-L1 antibodies in patients with non-small cell lung cancer","volume":"139","author":"Ichihara","year":"2020","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2022.10.013_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204729","article-title":"Body mass index may predict the response to ipilimumab in metastatic melanoma: an observational multi-centre study","volume":"13","author":"Richtig","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.013_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001117","article-title":"Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study","volume":"8","author":"Rutkowski","year":"2020","journal-title":"J Immunother cancer"},{"key":"10.1016\/j.ejca.2022.10.013_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.668494","article-title":"Re-evaluating the effects of obesity on cancer immunotherapy outcomes in renal cancer: what do we really know?","volume":"12","author":"Farag","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ejca.2022.10.013_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2022.10.013_bib15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2022.10.013_bib16","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1002\/cam4.3428","article-title":"Sarcopenia and adverse health-related outcomes: an umbrella review of meta-analyses of observational studies","volume":"9","author":"Xia","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ejca.2022.10.013_bib17","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41598-020-58498-2","article-title":"Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1\/PD-L1 checkpoint inhibitors: a multicenter real-life study","volume":"10","author":"Cortellini","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ejca.2022.10.013_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8040450","article-title":"Association of sarcopenia with and efficacy of anti-PD-1\/PD-L1 therapy in non-small-cell lung cancer","volume":"8","author":"Nishioka","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejca.2022.10.013_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111345","article-title":"Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: a comprehensive systematic review and meta-analysis","volume":"90","author":"Deng","year":"2021","journal-title":"Nutrition"},{"issue":"7","key":"10.1016\/j.ejca.2022.10.013_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019059","article-title":"Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer","volume":"99","author":"Tsukagoshi","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.ejca.2022.10.013_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2016.05.031","article-title":"Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1\/-L1 therapy","volume":"65","author":"Dercle","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejca.2022.10.013_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamaoncol.2017.4771","article-title":"Association of the lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer","volume":"4","author":"Mezquita","year":"2018","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2022.10.013_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SPC.0000000000000457","article-title":"From cachexia to obesity: the role of host metabolism in cancer immunotherapy","volume":"13","author":"Brocco","year":"2019","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.ejca.2022.10.013_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576314","article-title":"Obesity, sarcopenia, and outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors","volume":"10","author":"Khaddour","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2022.10.013_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105745","article-title":"The prognostic role of obesity is independent of sex in cancer patients treated with immune checkpoint inhibitors: a pooled analysis of 4090 cancer patients","volume":"74","author":"Xu","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.ejca.2022.10.013_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12967-020-02404-x","article-title":"Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"18","author":"An","year":"2020","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.ejca.2022.10.013_bib27","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.annonc.2020.12.012","article-title":"Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data","volume":"32","author":"Di Filippo","year":"2021","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.013_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000821","article-title":"Impact of body composition on outcomes from anti-PD1 +\/- anti-CTLA-4 treatment in melanoma","volume":"8","author":"Young","year":"2020","journal-title":"J Immunother cancer"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.013_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001674","article-title":"Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer","volume":"8","author":"Johannet","year":"2020","journal-title":"J Immunother cancer"},{"key":"10.1016\/j.ejca.2022.10.013_bib30","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.2147\/CMAR.S210958","article-title":"Correlation of body composition by computerized tomography and metabolic parameters with survival of nivolumab-treated lung cancer patients","volume":"11","author":"Magri","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejca.2022.10.013_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2020.03.003","article-title":"Cachexia \u2013 sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors","volume":"143","author":"Roch","year":"2020","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.013_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0448","article-title":"Outcomes among patients with or without obesity and with cancer following treatment with immune checkpoint blockade","volume":"5","author":"Yoo","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"9","key":"10.1016\/j.ejca.2022.10.013_bib33","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1245\/s10434-018-6652-x","article-title":"Assessment of computed tomography (CT)-Defined muscle and adipose tissue features in relation to short-term outcomes after elective surgery for colorectal cancer: a multicenter approach","volume":"25","author":"Martin","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2022.10.013_bib34","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00432-020-03146-5","article-title":"Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors","volume":"146","author":"Takada","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2022.10.013_bib35","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/s41598-019-39120-6","article-title":"Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: a preliminary retrospective study","volume":"9","author":"Shiroyama","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ejca.2022.10.013_bib36","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jcsm.12538","article-title":"Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma","volume":"11","author":"Chu","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.ejca.2022.10.013_bib37","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jso.24003","article-title":"Morphomics predicts response to ipilimumab in patients with stage IV melanoma","volume":"112","author":"Sabel","year":"2015","journal-title":"J Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejca.2022.10.013_bib38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ijo.2017.99","article-title":"The \u201cobesity paradox\u201d may not be a paradox at all","volume":"41","author":"Banack","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/j.ejca.2022.10.013_bib39","series-title":"5th UK causal inference meeting. Colchester","article-title":"Small steps towards big mediation","author":"Daniel","year":"2017"},{"issue":"2","key":"10.1016\/j.ejca.2022.10.013_bib40","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/jcsm.12956","article-title":"Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma","volume":"13","author":"Lee","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922013077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804922013077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:38:09Z","timestamp":1760733489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804922013077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"alternative-id":["S0959804922013077"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2022.10.013","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2022.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}